Alkermes Medicines & Focus: Serious Mental Illness

We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.

Videos from this campaign

Alkermes Pathways

Content from this campaign

Health & Healthcare

Alkermes Survey Explores Impact of Bipolar I Disorder Medication Side Effects
Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that a vast majority of respondents who live with bipolar I disorder experienced medication side effects that negatively impacted their daily lives.

Health & Healthcare

New Findings About Life With Bipolar 1 Disorder
Alkermes is committed to understanding the unique needs of people living with mental illness and supporting disease awareness and education. We know there’s much to be done.

Health & Healthcare

Results From The Harris Poll and Depression and Bipolar Support Alliance
Results from our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found an overwhelming majority of patients surveyed with bipolar 1 disorder felt it is a difficult and isolating experience.

Health & Healthcare

Alkermes Highlights Signs and Symptoms of Schizophrenia
Schizophrenia is a complex brain disorder that can significantly impact patients. Fortunately, there are treatment options that may help.

Health & Healthcare

New National Survey of People Living With Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey
Results from a newly released survey provide insights from adults living with bipolar I disorder in the United States on the burden of living with this serious mental health condition and their experiences with treatment.

Responsible Business & Employee Engagement

"I'm Incredibly Proud to Work at a Company Whose Mission Is To Help Families Like Mine"
Jessica Veri is an Alkermes employee whose personal connection to mental health inspires her to make a meaningful difference in the lives of people living with serious mental illness.

Health & Healthcare

Alkermes Celebrates Mental Health Month
May is Mental Health Month! The COVID-19 pandemic has put mental health front and center. This month we encourage everyone to learn more, share resources, and consider how you can support those who are living with mental illness.

Events, Media & Communications

Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May.

Health & Healthcare

Alkermes Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress of the Schizophrenia International Research Society
Alkermes plc (Nasdaq: ALKS) recently announced the presentation of new research from its psychiatry portfolio at the 2021 Congress of the Schizophrenia International Research Society (SIRS), taking place virtually April 17-21, 2021.

Health & Healthcare

Alkermes Supports Mental Health Clinical Research
Alongside the The STARR Coalition, we recognize the need to support mental health research. Scientific, evidence-based mental health research is essential.
Alkermes logo

More from Alkermes

  1. Alkermes: Diversity, Inclusion & Belonging
    Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...

  2. Alkermes: Corporate Responsibility
    We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research...

  3. Alkermes Medicines & Focus: Serious Mental Illness
    We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with...

  4. Alkermes Medicines & Focus: Cancer
    We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new...

  5. Alkermes Inspiration Grants®
    Since 2016, the Alkermes Inspiration Grants® program has awarded more than $4 million in funding to innovative programs that support the comprehensive...

  6. Alkermes Medicines & Focus: Addiction
    We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid...